Amgen reported $1.31B in Selling and Administration Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Abbvie ABBV:US $ 2.98B 99M
Acceleron Pharma XLRN:US $ 45.11M 9.64M
Agios Pharmaceuticals AGIO:US $ 27.15M 2.06M
Alexion Pharmaceuticals ALXN:US $ 342.9M 101.5M
ALKERMES ALKS:US 136.21M 2.97M
Amgen AMGN:US $ 1.31B 79M
Astrazeneca AZN:US 2.99B 412M
Biogen BIIB:US $ 654.1M 16.8M
Biomarin Pharmaceutical BMRN:US $ 183.33M 828K
Bluebird Bio BLUE:US $ 68.28M 10.3M
Bristol Myers Squibb BMY:US $ 1.79B 95M
Coherus Biosciences CHRS:US $ 39.92M 420K
Dicerna Pharmaceuticals DRNA:US $ 21.99M 3.47M
Eli Lilly And LLY:US $ 1.58B 107.8M
Exelixis EXEL:US $ 101.56M 3.06M
Genmab GEN:DC 306M 42M
Gilead Sciences GILD:US $ 1.18B 173M
Glaxosmithkline GSK:US 2.5B 6M
GlaxoSmithKline GSK:LN 2.5B 6M
Intercept Pharmaceuticals ICPT:US $ 53.34M 4.32M
IONIS PHARMACEUT IONS:US $ 31M 25.46M
Johnson & Johnson JNJ:US $ 6B 73M
Merk MRK:US $ 2.27B 9M
Mirati Therapeutics MRTX:US $ 35.18M 5.57M
Moderna Inc MRNA:US 168M 47M
Neurocrine Biosciences NBIX:US $ 154.6M 11.4M
Novartis NVS:US 3.6B 109M
Novartis NOVN:VX 3.6B 109M
Pfizer PFE:US $ 2.73B 61M
Ptc Therapeutics PTCT:US $ 69.25M 374K
Puma Biotechnology PBYI:US $ 26.08M 13.33M
Regeneron Pharmaceuticals REGN:US $ 445M 30.3M
Sarepta Therapeutics SRPT:US $ 61.13M 11.22M
Seattle Genetics SGEN:US $ 180.28M 15.15M
Takeda 4502:JP 212.01B 7.83B
Teva Pharmaceutical TEVA:IT 864M 32M
Ultragenyx Pharmaceutical RARE:US $ 53.88M 473K
Vertex Pharmaceuticals VRTX:US $ 198.19M 3.52M
YTE INCY:US $ 190.7M 21.84M